Richard C. Rosenzweig - 03 Mar 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Mar 2025, 18:29:20 UTC
Prior SEC filing
14 Jan 2025
Next SEC filing
28 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Lindi Barton-Brobst, Attorney-In-Fact for Richard C. Rosenzweig

Key filing fact

Richard C. Rosenzweig filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 05 Mar 2025.

Key facts

  • This page summarizes Richard C. Rosenzweig's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
  • 5 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Mar 2025, 18:29.

Change

  • Previous filing in this sequence was filed on 14 Jan 2025.
  • Current net transaction value: -$124,914.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value
$0
Shares
+33,771
Change %
+59%
Price
$0.000000
Shares after
90,671
Date
03 Mar 2025
Ownership
Direct
Footnotes
F1
XRAY transaction

Common Stock

Tax liability

Transaction value
$23,217
Shares
-1,452
Change %
-1.6%
Price
$15.99
Shares after
89,219
Date
03 Mar 2025
Ownership
Direct
Footnotes
F2
XRAY transaction

Common Stock

Tax liability

Transaction value
$79,246
Shares
-4,956
Change %
-5.6%
Price
$15.99
Shares after
84,263
Date
03 Mar 2025
Ownership
Direct
Footnotes
F2
XRAY transaction

Common Stock

Tax liability

Transaction value
$22,450
Shares
-1,440
Change %
-1.7%
Price
$15.59
Shares after
82,823
Date
04 Mar 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+350,100
Change %
Price
$0.000000
Shares after
350,100
Date
03 Mar 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
350,100
Exercise price
$15.99
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Award consists entirely of Restricted Stock Units (RSUs) which vest in annual one-third (1/3) increments over a three-year period ending 3/3/2028.

Footnote F2

Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.

Footnote F3

Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2028.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .